设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
CNKI学位论文(22)
知网期刊论文(6)
在“
Elsevier电子期刊
”中,
命中:
10
条,耗时:0.0369839 秒
在所有数据库中总计命中:
28
条
1.
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
作者:
Dr Toni K Choueiri
;
MD
a
;
toni_choueiri@dfci.harvard.edu" class="auth_mail" title="E-mail the corresponding author
;
Bernard
Escudier
;
MD
b
;
Prof
Thomas Powles
;
MD
c
;
Prof
Nizar M Tannir
;
MD
d
;
Paul N Mainwaring
;
MD
e
;
Prof
Brian I Rini
;
MD
f
;
Hans J Hammers
;
MD
g
;
Frede Donskov
;
MD
h
;
Prof
Bruce J Roth
;
MD
i
;
Katriina Peltola
;
MD
j
;
Prof
Jae Lyun Lee
;
MD
k
;
Daniel Y C Heng
;
MD
l
;
Prof
Manuela Schmidinger
;
MD
m
;
Neeraj Agarwal
;
MD
n
;
Prof
Cora N Sternberg
;
MD
o
;
David F McDermott
;
MD
p
;
Dana T Aftab
;
PhD
q
;
Colin Hessel
;
MS
q
;
Christian Scheffold
;
MD
q
;
Gisela Schwab
;
MD
q
;
Prof
Thomas E Hutson
;
DO
r
;
Sumanta Pal
;
MD
s
;
Prof
Robert J Motzer
;
MD
t
;
for the METEOR investigators
刊名:The Lancet Oncology
出版年:2016
2.
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
作者:
Dr
Prof
Robert J Motzer
;
MD
a
;
motzerr@mskcc.org" class="auth_mail
;
Camillo Porta
;
MD
b
;
Prof
Nicholas J Vogelzang
;
MD
c
;
Cora N Sternberg
;
MD
d
;
Prof
Cezary Szczylik
;
MD
e
;
Jakub Zolnierek
;
MD
f
;
Christian Kollmannsberger
;
MD
g
;
Sun Young Rha
;
MD
h
;
Georg A Bjarnason
;
MD
i
;
Prof
Bohuslav Melichar
;
MD
j
;
Ugo De Giorgi
;
MD
k
;
Prof
Viktor Grü
;
nwald
;
MD
l
;
Ian D Davis
;
MBBS
m
;
Prof
Jae-Lyun Lee
;
MD
n
;
Prof
Emilio Esteban
;
MD
o
;
Gladys Urbanowitz
;
MBA
p
;
Can Cai
;
PhD
p
;
Matthew Squires
;
PhD
q
;
Mahtab Marker
;
PhD
p
;
Michael M Shi
;
MD
p
;
Prof
Bernard
Escudier
;
MD
r
刊名:Lancet Oncology
出版年:March, 2014
3.
Radiotherapy for renal-cell carcinoma
作者:
Prof
Gert De Meerleer
;
MD
a
;
gert.demeerleer@ugent.be" class="auth_mail
;
Vincent Khoo
;
MD
c
;
Bernard
Escudier
;
MD
d
;
Steven Joniau
;
PhD
f
;
Alberto Bossi
;
MD
e
;
Piet Ost
;
MD
a
;
Alberto Briganti
;
MD
g
;
Valé
;
rie Fonteyne
;
MD
a
;
Marco Van Vulpen
;
MD
h
;
Nicolaas Lumen
;
PhD
b
;
Martin Spahn
;
MD
i
;
Prof
Marc Mareel
;
MD
a
刊名:Lancet Oncology
出版年:April, 2014
4.
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
作者:
Dr Robert J Motzer
;
MD
a
;
motzerr@mskcc.org
;
Bernard
Escudier
;
MD
b
;
Piotr Tomczak
;
MD
c
;
Thomas E Hutson
;
DO
d
;
M Dror Michaelson
;
MD
e
;
Prof
Sylvie Negrier
;
MD
f
;
Prof
Stephane Oudard
;
MD
g
;
Prof
Martin E Gore
;
MD
h
;
Jamal Tarazi
;
MD
i
;
Subramanian Hariharan
;
MD
j
;
Connie Chen
;
PharmD
k
;
Brad Rosbrook
;
MS
i
;
Sinil Kim
;
MD
i
;
Brian I Rini
;
MD
l
刊名:Lancet Oncology
出版年:2013
5.
mRCC management: past, present and future
作者:
Manuela Schmidinger
;
Martin Gore
;
Camillo Porta
;
Sylvie N¨¦grier
;
Bernard
Escudier
关键词:
Metastatic renal cell carcinoma
;
mRCC
;
Therapy management
;
Targeted agents
;
Sunitinib
;
Temsirolimus
刊名:European Journal of Cancer Supplements
出版年:2012
6.
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial
作者:
Prof
Sylvie Né
;
grier MD
a
;
negrier@lyon.fnclcc.fr"" rel=""nofollow
;
Gwenaë
;
lle Gravis MD
c
;
David Pé
;
rol MD
b
;
Christine Chevreau MD
d
;
Ré
;
my Delva MD
e
;
Prof
Jacques-Olivier Bay MD
f
;
Ellen Blanc MSc
b
;
Cé
;
line Ferlay MSc
b
;
Lionnel Geoffrois MD
g
;
Fré
;
dé
;
ric Rolland MD
h
;
Eric Legouffe MD
i
;
Emmanuel Sevin MD
j
;
Brigitte Laguerre MD
k
;
Bernard
Escudier
MD
l
刊名:Lancet Oncology
出版年:2011
7.
Long-term safety of sorafenib in advanced renal cell carcinoma: Follow-up of patients from phase III TARGET
作者:
Thomas E. Hutson
;
Joaquim Bellmunt
;
Camillo Porta
;
Cezary Szczylik
;
Michael Staehler
;
Andrea Nadel
;
Sibyl Anderson
;
Ronald Bukowski
;
Tim Eisen
;
Bernard
Escudier
;
For the Sorafenib TARGET Clinical Tri
关键词:
Renal cell carcinoma
;
Long-term safety
;
Sorafenib
;
Tolerability
;
TARGET
;
Disease stabilisation
刊名:European Journal of Cancer
出版年:2010
8.
Trastuzumab versus lapatinib: The cardiac side of the story
作者:
Hamdy Azim
;
Hatem A. Azim Jr.
;
Bernard
Escudier
关键词:
HER2
;
Lapatinib
;
Trastuzumab
;
Cardiac toxicity
刊名:Cancer Treatment Reviews
出版年:2009
9.
The medical treatment of metastatic renal cell cancer in the elderly: Position paper of a SIOG Taskforce
作者:
Joaquim Bellmunt
;
Sylvie Né
;
grier
;
Bernard
Escudier
;
Ahmad Awada
;
Matti Aapro
关键词:
Metastatic renal cell cancer
;
Elderly
;
Sunitinib
;
Temsirolimus
;
Sorafenib
;
Bevacizumab
;
Interferon
刊名:Critical Reviews in Oncology/Hematology
出版年:2009
10.
New Perspectives: An Oral Multikinase Inhibitor in Patients with Advanced RCC
作者:
Bernard
Escudier
关键词:
Advanced renal cell cancer
;
Clinical benefit
;
Overall survival
;
Phase 3 trial
;
Progression-free survival
;
Sorafenib
刊名:European Urology Supplements
出版年:2007
1
按检索点细分(10)
作者(5)
按出版年细分(10)
2027年及以后(2)
2016年(1)
2013年(1)
2012年(1)
2011年(1)
2010年(1)
2009年(2)
2007年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.